Cofactors provide redox carriers for biosynthetic reactions, catabolic reactions and act as important agents in transfer of energy for the cell. Recent advances in manipulating cofactors include culture conditions or additive alterations, genetic modification of host pathways for increased availability of desired cofactor, changes in enzyme cofactor specificity, and introduction of novel redox partners to form effective circuits for biochemical processes and biocatalysts. Genetic strategies to employ ferredoxin, NADH and NADPH most effectively in natural or novel pathways have improved yield and efficiency of large-scale processes for fuels and chemicals and have been demonstrated with a variety of microbial organisms.
Introduction
Cofactors provide redox carriers for biosynthetic reactions, catabolic reactions and act as important agents in transfer of energy for the cell. Some examples illustrating the requirement for cofactor balance and availability include: the conversion of biomass feedstocks containing xylose to ethanol where the formation of xylitol is a problem [1] [2] [3] [4] [5] [6] [7] ; as a driving force for more effective production of reduced compounds such as biofuels [8] ; in using cytochrome P450s in specific oxidation reactions where the recycling of active enzyme is required [9] [10] [11] ; and the production of chiral pharmaceutical intermediates where specific reductions require a certain cofactor [12, 13] . Experimental studies along with more complete computational models have shown a global picture of the flow of reducing equivalents and its connection to cell physiology and allowed these insights to be considered for metabolic engineering purposes [14] [15] [16] [17] . The synthetic biology revolution has allowed easier ways to construct combinations of redox complexes and connect them to give a focused controllable circuit that can be directed to a desired metabolite [18] . Advances in protein engineering also have helped direct cell redox metabolism toward desired ends [6, [19] [20] [21] [22] [23] . These advances intertwine with the theme of generating effective bioprocesses for fuels and chemicals from biomass and more recently from H 2 /CO 2 or electrodes [24, 25] . The brief review will cover some recent developments in analyzing redox flow in microbial cells and its physiological consequences [26] , engineering proteins and pathways for optimal performance and applications of cofactor engineering to commercial processes.
Studies connecting cofactor balance to cell physiology
The effect of extracellular additives on redox cofactor physiology has been observed in several reports. The addition of hydrogenase substrates/inhibitors can affect the availability of NADH and lead to higher butyrate formation in clostridium cultures [27] . Electron mediators such as methyl viologen or neutral red can also serve to increase butyrate productivity [28] and demonstrate potential for electrically driven acidogenesis. The addition of pyridine nucleotide precursors to the medium improved pools in E. coli and aided formation of a chiral pharmaceutical intermediate [29] . Experimental and modeling studies of the contribution of the pentose phosphate pathway in forming NADPH have been published. As demand for NADPH was increased, cells increased flux through the pentose phosphate and acetate pathways and employed a cytosolic transhydrogenase [15] . The group also developed a constraint-based model to analyze the contribution of pathways producing NADPH [14] supporting the findings and proposing, a glycerol-DHA futile cycle, could provide additional NADPH. These studies have shown a variety of effects of cofactor manipulation on cellular metabolism.
Recent studies of redox reactions in a variety of anaerobes has shown the importance of ferredoxins as electron carriers and the recent discovery of bifurcating systems coupling this cofactor to generating membrane gradients and regeneration of NADH/NADPH while catalyzing less energy requiring reductions has brought new appreciation to their role as major carriers of electron flow and allowed initial efforts to engineer such systems in a useful fashion. Ferredoxin is an electron transfer carrier with a low midpoint potential so the reduced form is a potent reducing agent. The analysis of the specificity of the partner and coupling mechanism have been active areas of research. The NADPH specificity of ferredoxin-NAD(P)H oxidoreductase (FNR) is often decided by the interaction at the 2'-phosphate group of NADPH. A Y308S mutation in the pea enzyme reduced its preference for NADPH [23] . Mutation Y258F in Plasmodium falciparum FNR deleted the hydroxyl group which interacts with the 2'-phosphate group of NADPH and abolished the enzyme's cofactor selectivity [30] The use of ferredoxin coupled reactions was creatively used in the formation of a synthetic hydrogen-producing electron transfer circuit in E. coli [18] . Heterologously expressed [Fe-Fe]-hydrogenase, ferredoxin, and pyruvate-ferredoxin oxidoreductase allowed production of hydrogen gas coupled to sugar metabolism. The synthetic pathway was "insulated" from normal host reactions by deletion of competing pathway genes and protein interactions were engineered by various protein fusions with Fd partners, and co-localization of pathway enzymes on heterologous protein scaffolds. Subsequently a novel use of RNA scaffolds in this system [37] showed a new way to localize and enhance cellular redox pathways and suggested additional opportunities for harnessing ferredoxin-mediated processes.
Cofactor considerations in metabolic engineering
While in general the reduced cofactor is the desired form, there are instances where it is useful to remove the reduced form and recycle NAD + . The use of NADH oxidase to remove excess NADH and aid formation of oxidized products has been reported previously. NADH oxidase from Lactobacillus brevis was overexpressed in combination with a (2R,3R)-2,3-butanediol dehydrogenase to produce chiral (3R)-acetoin as an example of specific formation of a chiral product [13] . The characterization of a new NADH oxidase from Streptococcus pyogenes MGAS10394 revealed it had the highest activity among known NADH oxidases [38] . A library bearing different strength noxE promoters was constructed to alter noxE expression and NADH/NAD + ratios in the lactic acid bacteria, which altered the distribution of lactate and diacetyl [39] . In a number of pathways NADPH is the reducing cofactor, so there have been several successful efforts to increase the availability of this cofactor in the host (Figure 1 ). Sources of NADPH include the pentose phosphate pathway, isocitrate dehydrogenase and malic enzyme. To increase NADPH, overexpression of a NAD kinase gene has been studied. In yeast a number of studies have been performed. The mitochrondrial NADH kinase Pos5p is important in generating the active FeS centers of a number of metabolic proteins [40] needed for respiration [41] . These studies showed significant physiological effects of altering the mitochondrial or cytoplasmic pool of NADPH. Overexpressing NADH kinase in the cytosol had varying effects on cell products depending on the conditions of growth on glucose, e.g. more to ethanol during aerobic growth and more to ethanol and acetate during anaerobic growth [42] . The strategy did not reduce the formation of xylitol in xylose cultures. In this regard, decreasing cytosolic NADH lowered glycerol production, while changes in product profile were linked to the ATP requirement for biomass synthesis and the efficiency of oxidative phosphorylation [43] . The yeast NAD kinase was expressed in E. coli to aid production of guanosine diphosphate (GDP)-L-fucose and epsiloncaprolactone with a 51 % and 96% enhancement observed, respectively [44] . The authors suggested the enhanced availability of NADPH through more efficient regeneration of NADPH and that it could be applied to other products. NAD kinase was also overexpressed generating a higher yield of lysine in Corynebacterium glutamicum [45] .
The native C. glutamicum NAD + dependent glyceraldehyde-3-phosphate dehydrogenase was replaced by a non-phosphorylating NADP + dependent GAPDH from Streptococcus mutans and an improved growth variant exhibited increased lysine production [46] . In an engineered xylitol producing E. coli strain, double deletions of phosphofructokinase pfk and transhydrogenase sthA or phosphoglucose isomerase pgi and sthA genes were made and both combinations showed increased xylitol yield [47] . The NADPH supply in an engineered E. coli strain was improved by overexpression of fructose 1,6-bisphosphatase II glpX or co-expression of glpX and glucose-6-phosphate 1-dehydrogenase zwf [48] . We have shown that replacement of the E. coli native NAD + dependent GAPDH gapA by NADP + dependent GAPDH gapB from Bacillus subtilis increased product formation and the strain showed further increased NADPH dependent biosynthesis when NAD kinase was co-expressed (unpublished results). In another strategy, phosphofructokinase has been deleted from E. coli [49] [50] [51] and studied in various combinations with other alterations such as GAPDH overexpression, NAD kinase, glucose uptake systems and transhydrogenase alterations. The altered glycolysis in pfk mutants routed glucose through pentose phosphate pathway and led to higher NADPH dependent biosynthesis in systems sensitive to NADPH availability reported in [49] [50] [51] and found by our group [52] . Xylitol formation using NADPH-dependent xylose reductase from Candida boidinii was improved in an E. coli pfkA and sthA mutant [51] . Deletion of pgi and sthA also showed increased glucose utilization and lowered acetate formation.
One of the options is to increase the activity of transhydrogenases that can convert excess NADH into NADPH. In E. coli two systems exist, membrane associated PntAB and a soluble Udh or Sth system. Our group (Jan et al, unpublished) and other researchers have combined overexpression or deletion of these genes with other host strain modifications to improve NADPH-dependent pathway performance where NADPH availability is measured in the presence of a NADPH utilizing reaction or "sink". In E. coli engineered for xylitol [53] or platform chemical 3-hydroxypropionic acid production [54] , PntAB increased production.
Studies of Corynebacterium glutamicum engineered for isobutanol formation indicated a cycle consisting of pyruvate and/or phosphoenolpyruvate carboxylase, malate dehydrogenase, and malic enzyme provided conversion of NADH + H + to NADPH + H + , aided synthesis [55] . Engineering C. glutamicum for valine production by removing pyruvate dehydrogenase activity enhanced flux through the pentose phosphate pathway providing additional NADPH while adding E. coli PntAB decreased the pentose phosphate pathway flux [56] .
Another way to address the NADH/NADPH balance problem in an engineered organism is to convert an enzyme's cofactor specificity to the desired characteristic. Production of 1,3-propanediol by1,3-propanediol oxidoreductase is limited by NADPH. To broaden cofactor specificity, the Asp41 interacting with the phosphate group of NADPH was changed to Gly allowing use of both cofactors [57] . In producing isobutanol, NADPH dependent keto-acid reductoisomerase and alcohol dehydrogenase were engineered into NADH dependent variants. The reconstructed isobutanol biosynthetic pathway resulted in 100% theoretical yield [19, 21] . Formate dehydrogenase, which oxidizes formate into carbon dioxide, is widely used to regenerate reduced cofactors. The FDH from Mycobacterium vaccae N10 was mutated on the conserved NAD + binding motif to give a NADPH dependent activity [58] more resistant to haloketones.
Cofactor engineering in large-scale processes helps achieve optimal performance.
A number of articles have focused on limiting glycerol byproduct formation during yeast ethanol fermentation. A limitation in yeasts engineered to consume xylose is the formation of xylitol and the cofactor imbalance due to the usual NADPH-preferring xylose reductase and the NADdependent xylitol dehydrogenase. Routes to overcome these limitations have used deletion of the NAD + -dependent glycerol-3-phosphate dehydrogenase gene while introducing a nonphosphorylating NADP + -dependent glyceraldehyde-3-phosphate dehydrogenase [2, 3, 5] . Overexpression of a Kluyveromyces lactis NADPH-forming GAPDH reduced xylitol production [1] . Protein engineering of xylose reductase to a NADH-preferring enzyme gave high ethanol productivity [6] . A study with the NADH-NADPH utilizing Scheffersomyces stipitis xylose reductase suggested formation of glucose 6-phosphate via gluconeogenesis was limiting [4] . The expression of NADH oxidase to diminish cofactor imbalance lowered glycerol and xylitol yields while improving the ethanol yield [7] . Models suggested cofactor balancing in the engineered Dxylose utilization pathways would generate an increase in ethanol production while reducing time and suggested harmonizing cofactor usage would be worthwhile [16] .
The driving force for reactions in vivo was examined in 1-butanol synthesis. A modified clostridial 1-butanol pathway was introduced into E. coli and steps were taken to create NADH and acetyl-CoA to help direct the flux. Competing pathways in the host were removed and E. coli atoB was used for formation of acetoacetyl-CoA. The intracellular NADH driving force was further stimulated by employing formate dehydrogenase from C. boidinii [8] . The group also used an ATP driven step to form acetoacetyl-CoA for butanol formation in a cyanobacterium [59] . A model of butanol and isobutanol biosynthesis noted the importance of cofactor utilization [17] .
Other examples include the production of thymidine, where a mutation in pgi to divert more flux through the pentose pathway and employment of a NAD kinase and transhydrogenase UdhA, each increased yields of thymidine [60] . A lactic acid bacteria based system that could convert fructose to mannitol, in high yield also employed a cofactor regeneration system [61] .
Cofactor recycling: specialized enzyme systems.
Cytochrome P450 reactions require extensive cofactor recycling. These oxygenases are important in drug metabolism and can perform specific chiral introduction of functional groups. Cytochrome P450-199A2 from Rhodopseudomonas palustris oxidizes para-substituted benzoic acids and has an associated [2Fe-2S] ferredoxin, palustrisredoxin, rather than ferredoxin [9] . Expression of a similar P450 in E. coli from a tricistronic construct generated a whole cell biocatalyst that efficiently oxidized (1R)-(+)-camphor to 5-exo-hydroxycamphor and limonene to (-)-perillyl alcohol [10] . Gordonia SoCg alkB (alkane 1-monooxygenase) was expressed in E. coli BL21 and in Streptomyces coelicolor M145, and both hosts acquired the ability to transform n-hexadecane into 1-hexadecanol [62] . An E. coli system composed of P450pyr triple mutant, ferredoxin reductase, glucose dehydrogenase and ferredoxin genes, was engineered to show a high activity and high chiral efficiency in forming valuable pharmaceutical intermediates [11] .
An in vitro system for producing and using NADPH was made from 12 enzymes and demonstrated high-yield formation of NAD(P)H from cellobiose when coupled with NADPH consumption by xylose reductase [63] . Such in vitro processing of sugars may allow a new route for biohydrogenation reactions. Another in vitro system used non-covalent immobilization of a cofactor regeneration system on functionalized single-walled carbon nanotubes to make the pharmaceutical intermediate 4-hydroxy-2-butanone [12] .
Conclusions
Fundamental studies of individual enzymes, pathway fluxes, and global physiological responses have provided essential information for cofactor engineering as an aid for industrial production of fuels and chemicals. Protein engineering of enzyme cofactor specificity and formation of artificially created active complexes have impact for future work. Advances in engineering of the host on a larger and more precise scale have contributed to improved availability of the desired cofactor. Such combinations of an engineered host with enhancement of a novel or native pathway have generated effective biocatalysts for bulk and specialty chemicals. The refinement of ideal redox chemistry through cofactor manipulation seems to have considerable potential in metabolic engineering and fits with trends in synthetic biology circuits and genome engineering.
The article demonstrates an advance in in vitro technology using a multienzyme strategy to oxidize sugar and capture the reducing equivalents to form another product. 
